The redox state of transglutaminase 2 controls arterial remodeling

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  van den Akker, Jeroen ^a   VanBavel, Ed ^a   van Geel, Remon ^b   Matlung, Hanke L ^a   Guvenc Tuna, Bilge ^a   Janssen, George M C ^c,d   van Veelen, Peter A ^c   Boelens, Wilbert C ^b   de Mey, Jo G R ^e   Bakker, Erik N T P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NETHERLANDS PROTEOMICS CENTRE   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; DITHIOTHREITOL; ENTACTIN; FIBRONECTIN; GLUTATHIONE TRANSFERASE; MATRIX PROTEIN; NITRIC OXIDE DONOR; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; SELENOPROTEIN P; CALCIMYCIN; CALCIUM IONOPHORE; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RECOMBINANT PROTEIN; REDUCING AGENT;

ARTERIAL CIRCULATION; ARTERIAL STIFFNESS; ARTICLE; CELL MEMBRANE PERMEABILITY; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME REGULATION; MALE; MASS SPECTROMETRY; MESENTERIC ARTERY; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE FIBER MEMBRANE; VASOCONSTRICTION; ANIMAL; ARTERY; C57BL MOUSE; CELL LINE; DRUG EFFECT; ENZYME ACTIVATION; GENETICS; METABOLISM;

ANIMALS; ARTERIES; CALCIMYCIN; CALCIUM IONOPHORES; CELL LINE; ENZYME ACTIVATION; GTP-BINDING PROTEINS; MALE; MICE; MICE, INBRED C57BL; MYOCYTES, SMOOTH MUSCLE; RECOMBINANT PROTEINS; REDUCING AGENTS; TRANSGLUTAMINASES;

EID: 80052050912     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023067     Document Type: Article

References (63)

1. Pistea A, Bakker EN, Spaan JA, Hardeman MR, van Rooijen N, et al. (2008) Small artery remodeling and erythrocyte deformability in L-NAME-induced hypertension: role of transglutaminases. J Vasc Res 45: 10-18.
2. Buus CL, Pourageaud F, Fazzi GE, Janssen G, Mulvany MJ, et al. (2001) Smooth muscle cell changes during flow-related remodeling of rat mesenteric resistance arteries. Circ Res 89: 180-186.
3. Pourageaud F, De Mey JG, (1997) Structural properties of rat mesenteric small arteries after 4-wk exposure to elevated or reduced blood flow. Am J Physiol 273: H1699-H1706.
4. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, et al. (2003) Prognostic significance of small-artery structure in hypertension. Circulation 108: 2230-2235.
5. VanBavel E, Bakker EN, Pistea A, Sorop O, Spaan JA, (2006) Mechanics of microvascular remodeling. Clin Hemorheol Microcirc 34: 35-41.
6. Bakker EN, Pistea A, VanBavel E, (2008) Transglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis. J Vasc Res 45: 271-278.
7. Eftekhari A, Rahman A, Schaebel LH, Chen H, Rasmussen CV, et al. (2007) Chronic cystamine treatment inhibits small artery remodelling in rats. J Vasc Res 44: 471-482.
8. Bakker EN, Pistea A, Spaan JA, Rolf T, de Vries CJ, et al. (2006) Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase: possible compensation by macrophage-derived factor XIII. Circ Res 99: 86-92.
9. Koller A, (2006) Flow-dependent remodeling of small arteries: the stimuli and the sensors are (still) in question. Circ Res 99: 6-9.
10. Langille BL, Dajnowiec D, (2005) Cross-linking vasomotor tone and vascular remodeling: a novel function for tissue transglutaminase? Circ Res 96: 9-11.
11. Bakker EN, Buus CL, Spaan JA, Perree J, Ganga A, et al. (2005) Small artery remodeling depends on tissue-type transglutaminase. Circ Res 96: 119-126.
12. Aeschlimann D, Thomazy V, (2000) Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect Tissue Res 41: 1-27.
13. Lorand L, Graham RM, (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4: 140-156.
14. Park D, Choi SS, Ha KS, (2010) Transglutaminase 2: a multi-functional protein in multiple subcellular compartments. Amino Acids 39 (3): 619-31.
15. Santhanam L, Tuday EC, Webb AK, Dowzicky P, Kim JH, et al. (2010) Decreased S-Nitrosylation of Tissue Transglutaminase Contributes to Age-Related Increases in Vascular Stiffness. Circ Res 107 (1): 117-25.
16. Zemskov EA, Janiak A, Hang J, Waghray A, Belkin AM, (2006) The role of tissue transglutaminase in cell-matrix interactions. Front Biosci 11: 1057-1076.
17. Verderio EA, Scarpellini A, Johnson TS, (2009) Novel interactions of TG2 with heparan sulfate proteoglycans: reflection on physiological implications. Amino Acids 36: 671-677.
18. Hasegawa G, Suwa M, Ichikawa Y, Ohtsuka T, Kumagai S, et al. (2003) A novel function of tissue-type transglutaminase: protein disulphide isomerase. Biochem J 373: 793-803.
19. Chen JS, Mehta K, (1999) Tissue transglutaminase: an enzyme with a split personality. Int J Biochem Cell Biol 31: 817-836.
20. Chowdhury ZA, Barsigian C, Chalupowicz GD, Bach TL, Garcia-Manero G, et al. (1997) Colocalization of tissue transglutaminase and stress fibers in human vascular smooth muscle cells and human umbilical vein endothelial cells. Exp Cell Res 231: 38-49.
21. Guilluy C, Rolli-Derkinderen M, Tharaux PL, Melino G, Pacaud P, et al. (2007) Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cells. J Biol Chem 282: 2918-2928.
22. Janiak A, Zemskov EA, Belkin AM, (2006) Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway. Mol Biol Cell 17: 1606-1619.
23. Stamnaes J, Pinkas DM, Fleckenstein B, Khosla C, Sollid LM, (2010) Redox regulation of transglutaminase 2 activity. Journal of Biological Chemistry.
24. Siegel M, Khosla C, (2007) Transglutaminase 2 inhibitors and their therapeutic role in disease states. Pharmacol Ther 115: 232-245.
25. van Hall T, Wolpert EZ, van Veelen P, Laban S, van der Meer M, et al. (2006) Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat Med 12: 417-424.
26. Wesselman JP, Kuijs R, Hermans JJ, Janssen GM, Fazzi GE, et al. (2004) Role of the Rhoa/Rho kinase system in flow-related remodeling of rat mesenteric small arteries in vivo. J Vasc Res 41: 277-290.
27. VanBavel E, Bakker EN, (2008) A vascular bone collector: arterial calcification requires tissue-type transglutaminase. Circ Res 102: 507-509.
28. Faverman L, Mikhaylova L, Malmquist J, Nurminskaya M, (2008) Extracellular transglutaminase 2 activates beta-catenin signaling in calcifying vascular smooth muscle cells. FEBS Lett 582: 1552-1557.
29. Johnson KA, Polewski M, Terkeltaub RA, (2008) Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells. Circ Res 102: 529-537.
30. Matlung HL, Groen HC, de Vos J, van Walsum T, van der Lugt A, et al. (2009) Calcification locates to transglutaminases in advanced human atherosclerotic lesions. Am J Pathol 175: 1374-1379.
31. Matlung HL, VanBavel E, van den Akker J, de Vries CJ, Bakker EN, (2010) Role of transglutaminases in cuff-induced atherosclerotic lesion formation in femoral arteries of ApoE3 Leiden mice. Atherosclerosis.
32. Bakker EN, van der Meulen ET, van den Berg BM, Everts V, Spaan JA, et al. (2002) Inward remodeling follows chronic vasoconstriction in isolated resistance arteries. J Vasc Res 39: 12-20.
33. Bakker EN, Buus CL, VanBavel E, Mulvany MJ, (2004) Activation of resistance arteries with endothelin-1: from vasoconstriction to functional adaptation and remodeling. J Vasc Res 41: 174-182.
34. Benhar M, Forrester MT, Stamler JS, (2009) Protein denitrosylation: enzymatic mechanisms and cellular functions. Nat Rev Mol Cell Biol 10: 721-732.
35. Berndt C, Lillig CH, Holmgren A, (2007) Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. Am J Physiol Heart Circ Physiol 292: H1227-H1236.
36. Biswas S, Chida AS, Rahman I, (2006) Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem Pharmacol 71: 551-564.
37. Connellan JM, Folk JE, (1969) Mechanism of the inactivation of guinea pig liver transglutaminase by 5,5′-dithiobis-(2-nitrobenzoic acid). J Biol Chem 244: 3173-3181.
38. Lai TS, Hausladen A, Slaughter TF, Eu JP, Stamler JS, et al. (2001) Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry 40: 4904-4910.
39. Nemes Z, Petrovski G, Csosz E, Fesus L, (2005) Structure-function relationships of transglutaminases-a contemporary view. Prog Exp Tumor Res 38: 19-36.
40. Chung SI, Folk JE, (1970) Mechanism of the inactivation of guinea pig liver transglutaminase by tetrathionate. J Biol Chem 245: 681-689.
41. Pinkas DM, Strop P, Brunger AT, Khosla C, (2007) Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol 5: e327.
42. Waypa GB, Marks JD, Guzy R, Mungai PT, Schriewer J, et al. (2010) Hypoxia triggers subcellular compartmental redox signaling in vascular smooth muscle cells. Circ Res 106: 526-535.
43. Sippel TO, (1978) The histochemistry of thiols and disulphides. III. Staining patterns in rat tissues. Histochem J 10: 597-609.
44. Wolin MS, (2009) Reactive oxygen species and the control of vascular function. Am J Physiol Heart Circ Physiol 296: H539-H549.
45. Barron JT, Sasse MF, Nair A, (2004) Effect of angiotensin II on energetics, glucose metabolism and cytosolic NADH/NAD and NADPH/NADP redox in vascular smooth muscle. Mol Cell Biochem 262: 91-99.
46. Zhang G, Matsumura Y, Matsumoto S, Hayashi Y, Mori T, (2003) Effects of Ca2+ and sulfhydryl reductant on the polymerization of soybean glycinin catalyzed by mammalian and microbial transglutaminases. J Agric Food Chem 51: 236-243.
47. Ientile R, Caccamo D, Griffin M, (2007) Tissue transglutaminase and the stress response. Amino Acids 33: 385-394.
48. Shin DM, Jeon JH, Kim CW, Cho SY, Kwon JC, et al. (2004) Cell Type-specific Activation of Intracellular Transglutaminase 2 by Oxidative Stress or Ultraviolet Irradiation. Journal of Biological Chemistry 279: 15032-15039.
49. Jeong EM, Kim CW, Cho SY, Jang GY, Shin DM, et al. (2009) Degradation of transglutaminase 2 by calcium-mediated ubiquitination responding to high oxidative stress. FEBS Lett.
50. Shin DM, Jeon JH, Kim CW, Cho SY, Lee HJ, et al. (2008) TGFbeta mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation. FASEB J 22: 2498-2507.
51. Luciani A, Villella VR, Vasaturo A, Giardino I, Raia V, et al. (2009) SUMOylation of tissue transglutaminase as link between oxidative stress and inflammation. J Immunol 183: 2775-2784.
52. Bernassola F, Rossi A, Melino G, (1999) Regulation of transglutaminases by nitric oxide. Ann N Y Acad Sci 887: 83-91.
53. Pistea A, Bakker EN, Spaan JA, VanBavel E, (2005) Flow inhibits inward remodeling in cannulated porcine small coronary arteries. Am J Physiol Heart Circ Physiol 289: H2632-H2640.
54. Strom A, Olin AI, Aspberg A, Hultgardh-Nilsson A, (2006) Fibulin-2 is present in murine vascular lesions and is important for smooth muscle cell migration. Cardiovasc Res 69: 755-763.
55. Aeschlimann D, Paulsson M, (1991) Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization. J Biol Chem 266: 15308-15317.
56. Di Niro R, Sulic AM, Mignone F, D'Angelo S, Bordoni R, et al. (2010) Rapid interactome profiling by massive sequencing. Nucleic Acids Res.
57. Facchiano A, Facchiano F, (2009) Transglutaminases and their substrates in biology and human diseases: 50 years of growing. Amino Acids 36: 599-614.
58. Piredda L, Farrace MG, Lo BM, Malorni W, Melino G, et al. (1999) Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis. FASEB J 13: 355-364.
59. Ehrmann J Jr, Kolek A, Kod'ousek R, Zapletalova J, Lisova S, et al. (2003) Immunohistochemical study of the apoptotic mechanisms in the intestinal mucosa during children's coeliac disease. Virchows Arch 442: 453-461.
60. World CJ, Yamawaki H, Berk BC, (2006) Thioredoxin in the cardiovascular system. J Mol Med 84: 997-1003.
61. Soderberg A, Sahaf B, Rosen A, (2000) Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma. Cancer Res 60: 2281-2289.
62. Janiszewski M, Lopes LR, Carmo AO, Pedro MA, Brandes RP, et al. (2005) Regulation of NAD(P)H oxidase by associated protein disulfide isomerase in vascular smooth muscle cells. J Biol Chem 280: 40813-40819.
63. Thiele M, Bernhagen J, (2005) Link between macrophage migration inhibitory factor and cellular redox regulation. Antioxid Redox Signal 7: 1234-1248.